Recent Posts on This Topic | See All >
Study supports ASU researchers' pioneering work in cancer screeningTags: arizona state university, biodesign institute, bioimaging, cancer
[Source: ASU News] - The National Cancer Institute (NCI) has released the initial results from a large-scale clinical study of lung cancer screening methods that now provide confirmation of pioneering work led by ASU’s Biodesign Institute researchers. The study confirms that CT screening sharply reduces deaths from lung cancer by detecting cancers at relatively early stages.
The NCI’s National Lung Screening Trial (NLST), a randomized national trial involving more than 53,000 current and former heavy smokers ages 55 to 74, compared the effects of two screening procedures for lung cancer – low-dose helical computed tomography (CT) and standard chest X-ray – on lung cancer mortality and found 20 percent fewer lung cancer deaths among trial participants screened with low-dose helical CT.
For more information: Study supports ASU researchers' pioneering work in cancer screening
Now available: “Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is now available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” An overview by Walter Plosila, Ph.D., Battelle senior advisor, is also available. The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade.